In the past week, MAIA stock has gone up by 11.39%, with a monthly decline of -5.88% and a quarterly plunge of -20.00%. The volatility ratio for the week is 8.75%, and the volatility levels for the last 30 days are 8.36% for MAIA Biotechnology Inc The simple moving average for the last 20 days is 2.86% for MAIA stock, with a simple moving average of -32.53% for the last 200 days.
Is It Worth Investing in MAIA Biotechnology Inc (AMEX: MAIA) Right Now?
MAIA has 36-month beta value of 0.26. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MAIA is 19.05M, and currently, short sellers hold a 4.99% ratio of that float. The average trading volume of MAIA on March 21, 2025 was 276.37K shares.
MAIA) stock’s latest price update
The stock of MAIA Biotechnology Inc (AMEX: MAIA) has increased by 0.57 when compared to last closing price of 1.75. Despite this, the company has experienced a 11.39% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-03-20 that CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug.
MAIA Trading at -5.63% from the 50-Day Moving Average
After a stumble in the market that brought MAIA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.62% of loss for the given period.
Volatility was left at 8.36%, however, over the last 30 days, the volatility rate increased by 8.75%, as shares sank -7.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.56% lower at present.
During the last 5 trading sessions, MAIA rose by +11.39%, which changed the moving average for the period of 200-days by -62.95% in comparison to the 20-day moving average, which settled at $1.7110. In addition, MAIA Biotechnology Inc saw -11.11% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MAIA starting from Guerrero Ramiro, who purchase 33,333 shares at the price of $1.50 back on Mar 03 ’25. After this action, Guerrero Ramiro now owns 568,218 shares of MAIA Biotechnology Inc, valued at $50,000 using the latest closing price.
Smith Stan, the Director of MAIA Biotechnology Inc, purchase 25,000 shares at $1.50 during a trade that took place back on Mar 03 ’25, which means that Smith Stan is holding 1,205,060 shares at $37,500 based on the most recent closing price.
Stock Fundamentals for MAIA
The total capital return value is set at -3.26. Equity return is now at value -1188.16, with -319.37 for asset returns.
Currently, EBITDA for the company is -20.18 million with net debt to EBITDA at 0.4. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.56.
Conclusion
To put it simply, MAIA Biotechnology Inc (MAIA) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
